METMAX-GM2

METMAX-GM2 by Max Pharma is a powerful combination of Glimepiride and Metformin Hydrochloride (Prolonged-Release) formulated to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. This dual therapy improves insulin sensitivity, reduces hepatic glucose production, and promotes controlled release for sustained blood sugar management.

Why Choose METMAX-GM2 from Max Pharma?

• Dual-action control over blood glucose levels

• Sustained-release Metformin ensures long-lasting effect and minimal GI disturbances

• Helps in beta-cell stimulation and peripheral glucose uptake

• Manufactured by Max Pharma under stringent quality standards for efficacy and safety

Uses:

• Management of Type 2 Diabetes Mellitus

• First-line oral therapy in patients uncontrolled with diet and exercise

• Add-on therapy for better glycemic control in patients already on Metformin or Glimepiride

Dosage:
As prescribed by the physician, preferably with meals to reduce gastrointestinal side effects.

Precautions:

• Monitor blood glucose regularly

• Use cautiously in patients with kidney or liver impairment

• Not recommended for Type 1 Diabetes or diabetic ketoacidosis

METMAX-GM2 offers a reliable and clinically approved solution from Max Pharma for maintaining optimal blood sugar levels with a patient-friendly dosing profile.